2025
Diagnosis of Polycystic Ovary Syndrome and Non-Hispanic Black Race Are Predictive of Hypertension in Reproductive Age Women with Polycystic Ovary Syndrome
Okifo F, Pal L, Mushi M, Stachenfeld N. Diagnosis of Polycystic Ovary Syndrome and Non-Hispanic Black Race Are Predictive of Hypertension in Reproductive Age Women with Polycystic Ovary Syndrome. Journal Of Women's Health 2025 PMID: 40944506, DOI: 10.1177/15409996251376161.Peer-Reviewed Original ResearchPolycystic ovary syndromeHispanic womenInternational ClassificationNon-Hispanic Black (NHBAcademic health care systemNon-Hispanic black raceConfidence intervalsElectronic health recordsInternational Classification of DiseasesHealth care systemDiagnosis of polycystic ovary syndromeIndependent of polycystic ovary syndromePolycystic ovary syndrome casesObese Hispanic womenClass 3 obesityClassification of diseasesPre-metabolic syndromeBlood pressurePrediction of hypertensionObese PCOSNHB womenHealth recordsNon-HispanicCare systemHypertension incidenceComparative Rates of Acute Ischemic Stroke Incidence
Otite F, Morris N, Anikpezie N, Pitter D, Miller R, Bako A, Aneni E, Atchaneeyasakul K, Patel S, Sahoo A, Wee C, Albright K, Latorre J, Singla A, Khandelwal P, Williams O, Chaturvedi S, Ovbiagele B. Comparative Rates of Acute Ischemic Stroke Incidence. Neurology 2025, 105: e214105. PMID: 40865027, DOI: 10.1212/wnl.0000000000214105.Peer-Reviewed Original ResearchConceptsNon-Hispanic white individualsNon-Hispanic whitesSex-standardized incidenceSex-specific incidenceIncidence of acute ischemic strokeEthnic groupsIncident casesAcute ischemic strokeInternational ClassificationNon-Hispanic Black (NHBInpatient DatabaseInternational Classification of Diseases codesClassification of Diseases codesAsian individualsNew YorkUnited StatesPoisson regression modelsLook-back periodCensus dataRandom-effects Poisson regression modelsIncidence gapNHOPIDiseases codesState Ambulatory SurgeryNative Hawaiians
2024
Recurrence score gene axes scores and outcomes by race and ethnicity in the RxPONDER trial.
Abdou Y, Hoag J, Barlow W, Gralow J, Meric-Bernstam F, Albain K, Hayes D, Lin N, Perez E, Goldstein L, Chia S, Dhesy-Thind S, Rastogi P, Schott A, Racz J, Tripathy D, Hortobagyi G, Pusztai L, Sharma P, Kalinsky K. Recurrence score gene axes scores and outcomes by race and ethnicity in the RxPONDER trial. Journal Of Clinical Oncology 2024, 42: 515-515. DOI: 10.1200/jco.2024.42.16_suppl.515.Peer-Reviewed Original ResearchInvasive disease-free survivalNon-Hispanic whitesRecurrence scoreRacial/ethnic groupsTumor biologyRxPONDER trialNon-Hispanic Black (NHBBreast cancer outcomesDisease-free survivalMedian Follow-UpCox regression modelsAssociated with outcomeCancer-related genesSignificant healthcare concernCancer outcomesMenopausal statusPrognostic valueInferior outcomesHER2 signalingUnadjusted analysisTreatment armsFollow-upImpact of raceNHBHER2
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply